Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 1—January 2004

Rickettsia mongolotimonae Infection in South Africa

Article Metrics
citations of this article
EID Journal Metrics on Scopus
Anne-Marié Pretorius*Comments to Author  and Richard J. Birtles†
Author affiliations: *University of the Free State, Bloemfontein, South Africa; †University of Liverpool, Liverpool, United Kingdom

Cite This Article


We report the first laboratory-confirmed case of Rickettsia mongolotimonae infection in Africa. The patient sought treatment for an eschar on his toe; lymphangitis, severe headaches, and fever subsequently developed. After a regimen of doxycycline, symptoms rapidly resolved. R. mongolotimonae infection was diagnosed retrospectively by serologic tests and molecular-based detection of the organism in biopsy specimens of eschar material.

Rickettsioses are infections of emerging medical importance, particularly in southern Africa, where an increasing number of cases are being encountered among both residents and tourists (1). Three Rickettsia species have been associated with human disease in South Africa to date. Rickettsia conorii has long been recognized as the agent of Mediterranean spotted fever, and more recently, a newly recognized species, R. africae, has been identified as the agent of African tick-bite fever. In 2002, the first case report of a patient infected with R. aeschlimannii was published (2). In addition to these recognized pathogens, Rickettsia species, including R. mongolotimonae, have been detected in human-biting arthropods in Africa. This species (3) was first encountered in Hyalomma asiaticum ticks in Inner Mongolia in 1991 (4) but has subsequently been associated with human infections in southern France (5) and, perhaps of most relevance to this report, has been detected in H. truncatum ticks collected from cattle in Niger (6). This species of tick, which at least during its immature life stages parasitizes migratory birds, is widely distributed in many African countries, including South Africa (7).

The Study


Thumbnail of Eschar with lymphangitis.

Figure. Eschar with lymphangitis.

In September 2002, a 34-year-old (HIV-seronegative) construction worker, working near Ellisras in South Africa’s Northern Province, discovered a lesion on the inside of the second toe on his right foot (Figure); subsequently, severe headaches and high fever developed. He was examined at a local hospital and found to have lymphangitis extending pretibially from the lesion; as a result of his other symptoms, he was treated for blood poisoning with ceftriaxone sodium, 1,000 mg once daily. During the next 3 days, the lesion at the bite site (noted by the examining physician) remained very sore, and the patient’s right inguinal lymph node became enlarged and very painful. The patient then decided to return to his hometown and sought treatment from his general practitioner (on day 5 after discovery of the lesion). On examination, the lesion and lymphangitis were clearly visible on the patient’s toe, although cellulitis and edema were not observed. His inguinal lymph node had swollen to 3 cm in diameter, and he was still febrile (38.5°C). Blood samples were then obtained as well as a biopsy specimen from the lesion. A regimen of doxycycline, 100 mg per day orally, for 5 days was prescribed and 1 day’s dosage was administered. The next day, the patient was afebrile, and the lymphangitis had completely resolved.

In the laboratory, a Giemsa stain of a smear prepared from the patient’s blood showed activated lymphocytes. A complete blood count showed thrombocytosis (632 x 103/μL), but all other hematologic parameters were within the normal range. Biochemical findings showed elevated levels of alanine transaminase (66 IU/L), blood urea nitrogen (7.2 g/L), and triglycerides (2.2 mmol/L); and decreased levels of chloride (96.3 mmol/L) and albumin (38g/L); all other tests yielded results within the normal range. Testing of the patient’s serum with the Weil-Felix test demonstrated an antibody titer (80) only against the OX2 Proteus antigen, giving presumptive evidence of a rickettsial infection. As a result, antirickettsial microimmunofluorescence testing was performed (8). The serum did not yield significant immunoglobulin (Ig) M titers against R. conorii or R. africae antigens, but IgG titers of 64 were found by using both antigens. DNA was extracted from the eschar biopsy specimen by using the QIAamp Tissue kit (QIAGEN GmbH, Hilden, Germany) according to the manufacturer's instructions. This DNA extract was used as template in a previously described polymerase chain reaction assay targeting a Rickettsia spp. rOmpA fragment (9). An amplification product was obtained from this extract but not from any concurrently processed control materials. The amplification product was purified; the nucleic acid sequences of both strands were then determined. The sequence obtained from these efforts was found to share >99% similarity with the corresponding rOmpA fragment of R. mongolotimonae.


The combination of clinical and laboratory data yielded strong evidence that the case described here was an infection of R. mongolotimonae, the first reported in southern Africa. A single eschar is also typical of R. conorii infections, but these are characterized by rash (Mediterranean spotted fever), which the current patient did not have. Although R. africae infections manifest only rarely as a rash, they are typified by multiple eschars (10). This case description is also very similar to that relating to a French patient infected with R. mongolotimonae, who had lymphangitis and inguinal lymphadenopathy. The serologic findings indicate exposure to a spotted fever group rickettsia rather than to a specific species within this group, but the near identity of the rOmpA sequence obtained from the patient’s eschar to that of R. mongolotimonae provides a clear indication that this species, rather than other spotted fever group rickettsiae, was present at the site of the tick bite. Although no tick was found in association with the patient’s eschar, his infection may have been acquired from a H. truncatum, as this species is abundant in the region of the bushveld where the patient had been working and is known to feed on humans (11).

Dr. Pretorius is a medical scientist and lecturer. at the National Health Laboratory Services, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa. Her research interests include the clinical and epidemiologic features of vector-borne diseases, especially rickettsiae, ehrlichiae, and bartonellae.

Dr. Birtles is a senior lecturer at the Centre for Comparative Infectious Diseases, Department of Veterinary Pathology, Faculty of Veterinary Science, University of Liverpool, Liverpool, UK. His research interests are epidemiology, ecology and pathogenicity of bartonellae and other arthropod-borne bacteria, particularly in natural reservoir–vector systems.



  1. Raoult  D, Fournier  P-E, Fenollar  F, Jensenius  M, Prioe  T, De Pina  JJ, Rickettsia africae, a tick-borne pathogen of travellers to sub-saharan Africa. N Engl J Med. 2001;344:150410. DOIPubMedGoogle Scholar
  2. Pretorius  A-M, Birtles  RJ. Rickettsia aeschlimannii: a new pathogenic spotted fever group rickettsia, South Africa. Emerg Infect Dis. 2002;8:874.PubMedGoogle Scholar
  3. Raoult  D, Brouqui  P, Roux  V. A new spotted-fever-group rickettsiosis. Lancet. 1996;348:412. DOIPubMedGoogle Scholar
  4. Yu  X, Fan  M, Xu  G, Liu  Q, Raoult  D. Genotypic and antigenic identification of two new strains of spotted fever group rickettsiae isolated from China. J Clin Microbiol. 1993;31:838.PubMedGoogle Scholar
  5. Fournier  P-E, Tissot-Dupont  H, Gallais  H, Raoult  D. Rickettsia mongolotimonae: a rare pathogen in France. Emerg Infect Dis. 2000;6:2902.PubMedGoogle Scholar
  6. Parola  P, Inokuma  H, Camicas  J-L, Brouqui  P, Raoult  D. Detection and identification of spotted fever group rickettsiae and ehrlichiae in African ticks. Emerg Infect Dis. 2001;7:10147.PubMedGoogle Scholar
  7. Walker  J. A review of the Ixodid ticks (Acari, Ixodidae) occurring in southern Africa. Onderstepoort J Vet Res. 1991;58:81105.PubMedGoogle Scholar
  8. Teysseire  N, Raoult  D. Comparison of Western immunoblotting and microimmunofluorescence for diagnosis of Mediterranean spotted fever. J Clin Microbiol. 1992;30:45560.PubMedGoogle Scholar
  9. Roux  V, Fournier  P-E, Raoult  D. Differentiation of spotted fever group rickettsiae by sequencing and analysis of restriction fragment length polymorphism of PCR amplified DNA of the gene encoding the protein rOmpA. J Clin Microbiol. 1996;34:205865.PubMedGoogle Scholar
  10. Roux  V, Raoult  D. Rickettsioses as paradigms of new or emerging infectious diseases. Clin Microbiol Rev. 1997;10:694719.PubMedGoogle Scholar
  11. Horak  IG, Fourie  LJ, Heyne  H, Walker  JB, Needham  GR. Ixodid ticks feeding on humans in South Africa: with notes on preferred hosts, geographic distribution, seasonal occurrence and transmission of pathogens. Exp Appl Acarol. 2002;27:11336. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid1001.020662

Table of Contents – Volume 10, Number 1—January 2004

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Anne-Marié Pretorius, National Health Laboratory Services, Department of Medical Microbiology (G4), Faculty of Health Sciences, University of the Free State, PO Box 339, Bloemfontein, 9300 South Africa; fax: +27-51-444 3437

Send To

10000 character(s) remaining.


Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.